Overview

A Proof-of-Concept Study of Minocycline in Autism

Status:
Completed

Trial end date:
2020-10-30

Target enrollment:

Participant gender:

Summary

The purpose of the study is to determine if Minocycline shows initial evidence of efficacy, safety, and tolerability in youth with Autism Spectrum Disorder ages 12 to 22 years.

Phase:

Phase 1

Details

Lead Sponsor:

Children's Hospital Medical Center, Cincinnati

Treatments:

Minocycline